<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<html>
<head>
<title>O.U. Stetsiouk, E.L. Rjabkova, D.V. Galkin, 
M.V. Sukhorukova, L.S. Stratchounski  - The Results of IACMAC 
External Quality Assurance (Eqa) Program 
for Identification and Antimicrobial Susceptibility Testing (Ast)
of Gram-Positive Bacteria in Russia</title>
<meta name="description" content="The Results of IACMAC External Quality Assurance (Eqa) Program for Identification and Antimicrobial Susceptibility Testing (Ast) of Gram-Positive Bacteria in Russia">
<meta name="keywords" content="IACMAC, external quality assurance, Eqa, identification, antimicrobial susceptibility testing, Ast, gram-positive bacteria, russia, O.U. Stetsiouk, E.L. Rjabkova, D.V. Galkin, M.V. Sukhorukova, L.S. Stratchounski">
<script language="JavaScript1.2"> <!--//
function btn(ind,picture) {document.images[ind].src=picture;}
//--> </script>

<script language="JavaScript"> <!--// 
document.write('<link rel="StyleSheet" type="text/css" href="/en/inc/');
if (navigator.appName=="Netscape") {
	document.write("nn")
} else {
	document.write("ie")
}
document.write('.css">');
//-->
</script>
<noscript><link rel="StyleSheet" type="text/css" href="../../inc/ie.css"></noscript>

<style type="text/css">
P {margin-top: 10px; margin-left: 10px; text-align: justify;}
LI {margin-top: 8px; margin-left: 15px; text-align: justify;}
H4 {margin-left: 10px;}
H5 {font-size: 11pt}
H5.l {text-align: left;}
</style>
</head>

<body class="main">

<table width="750" cellpadding="0" border="0" cellspacing="5">
<tr>
  <th width="150" valign="top">

  <table border="0" cellpadding="5" cellspacing="0" width="100%">
    <tr><td>
<p class="m10"><b>Antimicrobial Resistance</b></p>
<hr size="1" style="color: #D0C0AC;">
<p class="m8"><a href="../index.shtml#rus">Antimicrobial Resistance in Russia</a></p>
<p class="m8"><a href="../index.shtml#pub">Publications</a></p>
<p class="m8"><a href="../links.shtml">References</a></p>

    </td></tr>
  </table>
  

  </th><td valign="top">
<!--navigation-->
<map name="TopBtnEn">
<area shape="circle" coords="15,15,15" href="javascript:history.go(-1)" alt="Previous page" title="Previous page">
<area shape="circle" coords="46,15,15" href="javascript:history.go(+1)" alt="Next page" title="Next page">
<area shape="circle" coords="77,15,15" href="../../index-1.htm" alt="Main page" title="Main page">
<area shape="circle" coords="108,15,15" href="mailto:website@antibiotic.ru" alt="E-Mail" title="E-Mail">
</map>
<table border="0" cellpadding="0" cellspacing="0" width="100%"> <!--1-->
<tr>
  <td bgcolor="#F8F3E6" background="/rus/images/buttons/topline.gif" style="background-color: #F8F3E6; background-image: url(../../../rus/images/buttons/topline.gif);" width="98%" height="32"><img src="../../../rus/images/inv.gif" width="1" height="32" border="0" alt=""></td>
  <td width="1%"><font size="1"><img src="../../../rus/images/buttons/topbtn.gif" width="126" height="32" border="0" alt="Navigation" usemap="#TopBtnEn"></font></td>
</tr>
</table>
<!--/navigation-->

<h2><a name="top"></a>22<sup>th</sup> International Congress of Chemotherapy</h2>
<h5><i>30 June - 3 July, 2001, Amsterdam, The Netherlands</i></h5>

<h1>The Results of IACMAC External Quality Assurance (Eqa) Program 
for Identification and Antimicrobial Susceptibility Testing (Ast)
of Gram-Positive Bacteria In Russia</h1>

<h5><i>O.U. STETSIOUK, E.L.&nbsp;RJABKOVA, D.V.&nbsp;GALKIN, M.V.&nbsp;SUKHORUKOVA, <u>L.S.&nbsp;STRATCHOUNSKI</u></i></h5>

<h5 class="l"><i>Scientific Center of Ministry of Health of Russian Federation for Monitoring of Antimicrobial Resistance<br>
Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy (IACMAC), RUSSIA<br>
Institute of Antimicrobial Chemotherapy, Smolensk, RUSSIA</i></h5>

<hr size="1">
<ul>
  <li><a href="#1">Abstract</a></li>
  <li><a href="#2">Introduction and objectives</a></li>
  <li><a href="#3">Materials and methods</a></li>
  <li><a href="#4">Results and discussion</a></li>
  <li><a href="#5">Conclusions</a></li>
  <li><a href="#6">Acknowledgments</a></li>
</ul>
<hr size="1">

<a name="1"></a><br>
<h2>ABSTRACT</h2>

<p><b>Objectives:</b> To assess ability of Russian laboratories to identify and detect clinically significant resistance of gram-positive bacteria.</p>

<p><b>Methods:</b> 53 laboratories in 28 Russian cities performed the following EQA tests: identification and AST of the 5 control strains of gram-positive bacteria granted by CDC (CDC-103 — CDC-107) to a defined set of antimicrobials.</p>

<p><b>Results:</b> Correct identification (<i>S.aureus</i> CDC-103, <i>S.aureus</i> CDC-104, <i>S.epidermidis</i> CDC-105, <i>E.faecalis</i> CDC-106 and <i>E.faecalis</i> CDC-107) to the species level was achieved in 86.3 — 88%, to the genus level — in 95.8-98% cases. Laboratories used for AST Russian AGV-medium and Mueller-Hinton agar. Agreement with the CDC AST results was attained in 55.6 (co-trimoxazole) — 100% for CDC-103, 73.9 (oxacillin) — 100% for CDC-104, 32 (oxacillin) — 100% for CDC-105, 17.2 (chloramphenicol) — 100% for CDC-106, and 0 (gentamicin) — 100% for CDC-107. High rate of major errors (25-44.4%) of co-trimoxazole AST can be explained by the use of AGV-medium with improper thimidine content. Unacceptable rate of very major errors was observed for oxacillin in <i>S.epidermidis</i> CDC-105 (64%) and for gentamicin in <i>E.faecalis</i> CDC-107 (88.9%).</p>

<p><b>Conclusions:</b> The obtained results show the vast need to implement in Russia internationally recognized standards for AST and detection of clinically significant resistance (MRSS, HLAGR) in gram-positive bacteria.</p> 

<a name="2"></a><br>
<h2>INTRODUCTION AND OBJECTIVES</h2>

<p>The impact of AST on effective antibacterial therapy is of increasing importance due to emergence and spread of antimicrobial resistance in bacteria. The results of AST <i>in&nbsp;vitro</i> serve as basis for administration of optimal antibiotic regimen for current patient, for empirical choice of antimicrobials and for creating of hospital formulary.</p>  

<p>Strict standardization of the testing procedure and regular performing of quality control tests are essential for achieving of repeatable clinically relevant results.</p> 

<p>The objectives of the current study were to assess ability of Russian laboratories to identify and detect clinically significant resistance of gram-positive bacteria.</p>

<a name="3"></a><br>
<h2>MATERIALS AND METHODS</h2>

<p>Fifty three (53) laboratories in 28 Russian cities performed the following EQA tests:</p>
<ul>
 	<li>Identification</li> 
 	<li>AST to a defined set of antimicrobials</li>
</ul>
<p>of the 5 control strains of gram-positive bacteria granted by CDC:</p>
<ul>
<li>CDC-103 (<i>S.aureus</i> ATCC 33591 — MRSA, <i>mecA</i>-positive)</li>
<li>CDC-104 (<i>S.aureus</i> ATCC 43387 — MSSA with <font face="Symbol">b</font>-lactamase hyperproduction)</li>
<li>CDC-105 (<i>S.epidermidis</i> — Vancomycin-Intermediate MRSE strain)</li>
<li>CDC-106 (<i>E.faecalis</i> — Vancomycin-Resistant strain, <i>vanA</i>-positive)</li>
<li>CDC-107 (<i>E.faecalis</i> ATCC 51299 — <i>vanB</i>-positive, recommended by NCCLS as control strain for vancomycin resistance screening test on BHI agar)</li>
</ul>

<a name="4"></a><br>
<h2>RESULTS AND DISCUSSION</h2>

<p>The participating laboratories used different media (Russian AGV-medium and Mueller-Hinton agar) and antimicrobial disks from different producers both domestic and imported.</p>

<p>Interpretation of the results was performed according to the &quot;Methodical Rules&quot; by Ministry of Health of USSR (1983), NCCLS guidelines (1995-98) and disk manufacturers’ recommendations.</p>

<p>Correct identification (<i>S.aureus</i> CDC-103, <i>S.aureus</i> CDC-104, <i>S.epidermidis</i> CDC-105, <i>E.faecalis</i> CDC-106 and <i>E.faecalis</i> CDC-107) to the genus level was achieved in 95.8 — 98.0% cases, to the species level in 86.3 — 88.0%.</p>

<p>Agreement with the CDC AST results was attained in 55.6 — 100% for CDC-103, 73.9 (oxacillin) — 100% for CDC-104, 32 (oxacillin) — 100% for CDC-105, 17.2 (chloramphenicol) — 100% for CDC-106, and 0 (gentamicin) — 100% for CDC-107.</p>

<p>The results are presented in <a href="#t1">Tables 1—5</a>. Minor errors are marked with green, major errors (false resistance) — in yellow, and very major errors (false susceptibility) — in red color.</p>

<p>High rate of major errors (25 — 44.4%) of trimethoprim/sulfamethoxazole AST can be explained by the use of AGV-medium with improper thimidine content.</p>

<p>Unacceptable rate of very major errors was observed for oxacillin in <i>S.epidermidis</i> CDC-105 (64%) and for gentamicin in <i>E.faecalis</i> CDC-107 (88.9%).</p> 

<a name="t1"></a><br>
<p><b>Table 1.</b> The results of identification and AST of CDC-103<br>(<i>S.aureus</i> ATCC 33591 — MRSA, <i>mecA</i>-positive)</p>

<table border="0" cellpadding="0" cellspacing="10" width="100%"><tr><td bgcolor="#CC9988">
<table width="100%" cellpadding="5" cellspacing="1" border="0">
<tr>
	<th width="25%" rowspan="2">Antimicrobial</th>
	<th width="30%" colspan="2">CDC results</th>
	<th width="45%" colspan="3">Q-ty (%) of Labs reporting the result as</th>
</tr>
<tr>
	<th width="15%">MIC, mg/L</th>
	<th width="15%">Zone, mm</th>
	<th width="15%">S</th>
	<th width="15%">I</th>
	<th width="15%">R</th>
</tr>
<tr>
	<td class="cl">Vancomycin</td>
	<td class="cc"><u>&lt;</u>1 (S)</td>
	<td class="cc">16 (S)</td>
	<td class="cc">35 (100)</td>
	<td class="cc">0 (0)</td>
	<td class="cc">0 (0)</td>
</tr>
<tr>
	<td class="cl">Gentamicin</td>
	<td class="cc"><u>&lt;</u>4 (S)</td>
	<td class="cc">17 (S)</td>
	<td class="cc">38 (92.7)</td>
	<td class="cc" style="background-color:#ccffcc;">1 (2.4)</td>
	<td class="cc" style="background-color:#ffffcc;">2 (4.9)</td>
</tr>
<tr>
	<td class="cl">Clindamycin</td>
	<td class="cc">&gt;8 (R)</td>
	<td class="cc">6 (R)</td>
	<td class="cc" style="background-color:#ffcccc;">1 (4.5)</td>
	<td class="cc" style="background-color:#ccffcc;">1 (4.5)</td>
	<td class="cc">20 (90.9)</td>
</tr>
<tr>
	<td class="cl">Co-trimoxazole</td>
	<td class="cc"><u>&lt;</u>0.25 (S)</td>
	<td class="cc">16 (S)</td>
	<td class="cc">5 (55.6)</td>
	<td class="cc">0 (0)</td>
	<td class="cc" style="background-color:#ffffcc;">4 (44.4)</td>
</tr>
<tr>
	<td class="cl">Oxacillin</td>
	<td class="cc">&gt;16 (R)</td>
	<td class="cc">6 (R)</td>
	<td class="cc" style="background-color:#ffcccc;">2 (7.4)</td>
	<td class="cc">0 (0)</td>
	<td class="cc">25 (92.6)</td>
</tr>
<tr>
	<td class="cl">Penicillin</td>
	<td class="cc">&gt;2 (R)</td>
	<td class="cc">6 (R)</td>
	<td class="cc">0 (0)</td>
	<td class="cc" style="background-color:#ccffcc;">1 (2.9)</td>
	<td class="cc">33 (97.1)</td>
</tr>
<tr>
	<td class="cl">Rifampicin</td>
	<td class="cc"><u>&lt;</u>0.12 (S)</td>
	<td class="cc">33 (S)</td>
	<td class="cc">20 (100)</td>
	<td class="cc">0 (0)</td>
	<td class="cc">0 (0)</td>
</tr>
<tr>
	<td class="cl">Tetracyclin</td>
	<td class="cc">&gt;16 (R)</td>
	<td class="cc">6 (R)</td>
	<td class="cc" style="background-color:#ffcccc;">1 (3.6)</td>
	<td class="cc">0 (0)</td>
	<td class="cc">27 (96.4)</td>
</tr>
<tr>
	<td class="cl">Chloramphenicol</td>
	<td class="cc">&gt;32 (R)</td>
	<td class="cc">8 (R)</td>
	<td class="cc" style="background-color:#ffcccc;">2 (7.7)</td>
	<td class="cc" style="background-color:#ccffcc;">3 (11.5)</td>
	<td class="cc">21 (80.8)</td>
</tr>
<tr>
	<td class="cl">Ciprofloxacin</td>
	<td class="cc"><u>&lt;</u>0.5 (S)</td>
	<td class="cc">25 (S)</td>
	<td class="cc">32 (88.9)</td>
	<td class="cc">0 (0)</td>
	<td class="cc" style="background-color:#ffffcc;">4 (11.1)</td>
</tr>
<tr>
	<td class="cl">Erythromycin</td>
	<td class="cc">&gt;8 (R)</td>
	<td class="cc">6 (R)</td>
	<td class="cc" style="background-color:#ffcccc;">3 (6.7)</td>
	<td class="cc">0 (0)</td>
	<td class="cc">42 (93.3)</td>
</tr>
<tr>
	<td class="cl">Identification</td>
	<td class="cc" colspan="2"><i>S.aureus</i></td>
	<td class="cc" colspan="3"><i>S.aureus</i> — 86.3%,<br><i>Staphylococcus</i> spp. — 9.8%</td>
</tr>
</table>
</td></tr></table>

<a name="t2"></a><br>
<p><b>Table 2.</b> The results of identification and AST of CDC-104<br>(<i>S.aureus</i> ATCC 43387 — MSSA with <font face="Symbol">b</font>-lactamase hyperproduction)</p>

<table border="0" cellpadding="0" cellspacing="10" width="100%"><tr><td bgcolor="#CC9988">
<table width="100%" cellpadding="5" cellspacing="1" border="0">
<tr>
	<th width="25%" rowspan="2">Antimicrobial</th>
	<th width="30%" colspan="2">CDC results</th>
	<th width="45%" colspan="3">Q-ty (%) of Labs reporting the result as</th>
</tr>
<tr>
	<th width="15%">MIC, mg/L</th>
	<th width="15%">Zone, mm</th>
	<th width="15%">S</th>
	<th width="15%">I</th>
	<th width="15%">R</th>
</tr>
<tr>
	<td class="cl">Vancomycin</td>
	<td class="cc"><u>&lt;</u>1 (S)</td>
	<td class="cc">15 (S)</td>
	<td class="cc">37 (100)</td>
	<td class="cc">0 (0)</td>
	<td class="cc">0 (0)</td>
</tr>
<tr>
	<td class="cl">Gentamicin</td>
	<td class="cc"><u>&lt;</u>1 (S)</td>
	<td class="cc">18 (S)</td>
	<td class="cc">39 (100)</td>
	<td class="cc">0 (0)</td>
	<td class="cc">0 (0)</td>
</tr>
<tr>
	<td class="cl">Clindamycin</td>
	<td class="cc">0.25 (S)</td>
	<td class="cc">22 (S)</td>
	<td class="cc">22 (100)</td>
	<td class="cc">0 (0)</td>
	<td class="cc">0 (0)</td>
</tr>
<tr>
	<td class="cl">Co-trimoxazole</td>
	<td class="cc"><u>&lt;</u>0.25 (S)</td>
	<td class="cc">25 (S)</td>
	<td class="cc">6 (75.0)</td>
	<td class="cc">0 (0)</td>
	<td class="cc" style="background-color:#ffffcc;">2 (25.0)</td>
</tr>
<tr>
	<td class="cl">Oxacillin</td>
	<td class="cc">2 (S)</td>
	<td class="cc">15 (S)</td>
	<td class="cc">17 (73.9)</td>
	<td class="cc" style="background-color:#ccffcc;">4 (17.4)</td>
	<td class="cc" style="background-color:#ffffcc;">2 (8.7)</td>
</tr>
<tr>
	<td class="cl">Penicillin</td>
	<td class="cc">&gt;2 (R)</td>
	<td class="cc">6 (R)</td>
	<td class="cc">0 (0)</td>
	<td class="cc" style="background-color:#ccffcc;">1 (2.8)</td>
	<td class="cc">35 (97.2)</td>
</tr>
<tr>
	<td class="cl">Rifampicin</td>
	<td class="cc"><u>&lt;</u>0.12 (S)</td>
	<td class="cc">29 (S)</td>
	<td class="cc">32 (100)</td>
	<td class="cc">0 (0)</td>
	<td class="cc">0 (0)</td>
</tr>
<tr>
	<td class="cl">Tetracyclin</td>
	<td class="cc"><u>&lt;</u> 0.25 (S)</td>
	<td class="cc">29 (S)</td>
	<td class="cc">25 (92.6)</td>
	<td class="cc" style="background-color:#ccffcc;">1 (3.7)</td>
	<td class="cc" style="background-color:#ffffcc;">1 (3.7)</td>
</tr>
<tr>
	<td class="cl">Chloramphenicol</td>
	<td class="cc">8 (S)</td>
	<td class="cc">18 (S)</td>
	<td class="cc">27 (100)</td>
	<td class="cc">0 (0)</td>
	<td class="cc">0 (0)</td>
</tr>
<tr>
	<td class="cl">Ciprofloxacin</td>
	<td class="cc">0.25 (S)</td>
	<td class="cc">29 (S)</td>
	<td class="cc">35 (100)</td>
	<td class="cc">0 (0)</td>
	<td class="cc">0 (0)</td>
</tr>
<tr>
	<td class="cl">Erythromycin</td>
	<td class="cc">0.5 (S)</td>
	<td class="cc">23 (S)</td>
	<td class="cc">43 (93.5)</td>
	<td class="cc" style="background-color:#ccffcc;">2 (4.3)</td>
	<td class="cc" style="background-color:#ffffcc;">1 (2.2)</td>
</tr>
<tr>
	<td class="cl">Identification</td>
	<td class="cc" colspan="2"><i>S.aureus</i></td>
	<td class="cc" colspan="3"><i>S.aureus</i> — 88.0%,<br><i>Staphylococcus</i> spp. — 10.0%</td>
</tr>
</table>
</td></tr></table>

<a name="t3"></a><br>
<p><b>Table 3.</b> The results of identification and AST of CDC-105<br>(<i>S.epidermidis</i> — MRSE, Vancomycin-Intermediate strain)</p>

<table border="0" cellpadding="0" cellspacing="10" width="100%"><tr><td bgcolor="#CC9988">
<table width="100%" cellpadding="5" cellspacing="1" border="0">
<tr>
	<th width="25%" rowspan="2">Antimicrobial</th>
	<th width="30%" colspan="2">CDC results</th>
	<th width="45%" colspan="3">Q-ty (%) of Labs reporting the result as</th>
</tr>
<tr>
	<th width="15%">MIC, mg/L</th>
	<th width="15%">Zone, mm</th>
	<th width="15%">S</th>
	<th width="15%">I</th>
	<th width="15%">R</th>
</tr>
<tr>
	<td class="cl">Vancomycin</td>
	<td class="cc">8 (I)</td>
	<td class="cc">16 (S)</td>
	<td class="cc">29 (90.6)</td>
	<td class="cc" style="background-color:#ccffcc;">2 (6.3)</td>
	<td class="cc" style="background-color:#ffffcc;">1 (3.1)</td>
</tr>
<tr>
	<td class="cl">Gentamicin</td>
	<td class="cc">16 (R)</td>
	<td class="cc">10 (R)</td>
	<td class="cc" style="background-color:#ffcccc;">15 (42.9)</td>
	<td class="cc">0 (0)</td>
	<td class="cc">20 (57.1)</td>
</tr>
<tr>
	<td class="cl">Clindamycin</td>
	<td class="cc">0.25 (S)</td>
	<td class="cc">25 (S)</td>
	<td class="cc">19 (100)</td>
	<td class="cc">0 (0)</td>
	<td class="cc">0 (0)</td>
</tr>
<tr>
	<td class="cl">Co-trimoxazole</td>
	<td class="cc">8 (R)</td>
	<td class="cc">8 (R)</td>
	<td class="cc" style="background-color:#ffcccc;">4 (50.0)</td>
	<td class="cc">0 (0)</td>
	<td class="cc">4 (50.0)</td>
</tr>
<tr>
	<td class="cl">Oxacillin</td>
	<td class="cc">&gt;16 (R)</td>
	<td class="cc">6 (R)</td>
	<td class="cc" style="background-color:#ffcccc;">16 (64.0)</td>
	<td class="cc" style="background-color:#ccffcc;">1 (4.0)</td>
	<td class="cc">8 (32.0)</td>
</tr>
<tr>
	<td class="cl">Penicillin</td>
	<td class="cc">&gt;2 (R)</td>
	<td class="cc">10 (R)</td>
	<td class="cc" style="background-color:#ffcccc;">2 (5.7)</td>
	<td class="cc">0 (0)</td>
	<td class="cc">33 (94.3)</td>
</tr>
<tr>
	<td class="cl">Rifampicin</td>
	<td class="cc"><u>&lt;</u>0.12 (S)</td>
	<td class="cc">31 (S)</td>
	<td class="cc">31 (100)</td>
	<td class="cc">0 (0)</td>
	<td class="cc">0 (0)</td>
</tr>
<tr>
	<td class="cl">Teicoplanin</td>
	<td class="cc">16 (I)</td>
	<td class="cc">14 (S)</td>
	<td class="cc">-</td>
	<td class="cc">-</td>
	<td class="cc">-</td>
</tr>
<tr>
	<td class="cl">Tetracyclin</td>
	<td class="cc"><u>&lt;</u>0.5 (S)</td>
	<td class="cc">24 (S)</td>
	<td class="cc">21 (91.3)</td>
	<td class="cc" style="background-color:#ccffcc;">1 (4.35)</td>
	<td class="cc" style="background-color:#ffffcc;">1 (4.35)</td>
</tr>
<tr>
	<td class="cl">Chloramphenicol</td>
	<td class="cc">8 (S)</td>
	<td class="cc">21 (S)</td>
	<td class="cc">21 (87.5)</td>
	<td class="cc">0 (0)</td>
	<td class="cc" style="background-color:#ffffcc;">3 (12.5)</td>
</tr>
<tr>
	<td class="cl">Ciprofloxacin</td>
	<td class="cc">&gt;8 (R)</td>
	<td class="cc">6 (R)</td>
	<td class="cc" style="background-color:#ffcccc;">4 (13.8)</td>
	<td class="cc">0 (0)</td>
	<td class="cc">25 (86.2)</td>
</tr>
<tr>
	<td class="cl">Erythromycin</td>
	<td class="cc">0.5 (S)</td>
	<td class="cc">26 (S)</td>
	<td class="cc">36 (90.0)</td>
	<td class="cc" style="background-color:#ccffcc;">1 (2.5)</td>
	<td class="cc" style="background-color:#ffffcc;">3 (7.5)</td>
</tr>
<tr>
	<td class="cl">Identification</td>
	<td class="cc" colspan="2"><i>S.epidermidis</i></td>
	<td class="cc" colspan="3"><i>S.epidermidis</i> — 86.7%, <i>Staphylococcus</i> spp. — 6.7%, <i>S.aureus</i> — 4.4%</td>
</tr>
</table>
</td></tr></table>

<a name="t4"></a><br>
<p><b>Table 4.</b> The results of identification and AST of CDC-106<br>(<i>E.faecalis</i> — Vancomycin-Resistant strain, <i>vanA</i>-positive)</p>

<table border="0" cellpadding="0" cellspacing="10" width="100%"><tr><td bgcolor="#CC9988">
<table width="100%" cellpadding="5" cellspacing="1" border="0">
<tr>
	<th width="25%" rowspan="2">Antimicrobial</th>
	<th width="30%" colspan="2">CDC results</th>
	<th width="45%" colspan="3">Q-ty (%) of Labs reporting the result as</th>
</tr>
<tr>
	<th width="15%">MIC, mg/L</th>
	<th width="15%">Zone, mm</th>
	<th width="15%">S</th>
	<th width="15%">I</th>
	<th width="15%">R</th>
</tr>
<tr>
	<td class="cl">Ampicillin</td>
	<td class="cc">1 (S)</td>
	<td class="cc">25 (S)</td>
	<td class="cc">36 (76.6)</td>
	<td class="cc" style="background-color:#ccffcc;">2 (4.3)</td>
	<td class="cc" style="background-color:#ffffcc;">9 (19.1)</td>
</tr>
<tr>
	<td class="cl">Vancomycin</td>
	<td class="cc">512 (R)</td>
	<td class="cc">6 (R)</td>
	<td class="cc" style="background-color:#ffcccc;">4 (10.5)</td>
	<td class="cc">0 (0)</td>
	<td class="cc">34 (89.5)</td>
</tr>
<tr>
	<td class="cl">High Level Gentamicin Resistance</td>
	<td class="cc">S<a href="#t4*">*</a></td>
	<td class="cc">19 (S)</td>
	<td class="cc">8 (88.9)</td>
	<td class="cc" style="background-color:#ccffcc;">1 (11.1)</td>
	<td class="cc">0 (0)</td>
</tr>
<tr>
	<td class="cl">High Level Streptomycin Resistance</td>
	<td class="cc">S<a href="#t4*">*</a></td>
	<td class="cc">16 (S)</td>
	<td class="cc">2 (40.0)</td>
	<td class="cc">-</td>
	<td class="cc" style="background-color:#ffffcc;">3 (60.0)</td>
</tr>
<tr>
	<td class="cl">Penicillin</td>
	<td class="cc">2 (S)</td>
	<td class="cc">18 (S)</td>
	<td class="cc">10 (29.4)</td>
	<td class="cc" style="background-color:#ccffcc;">7 (20.6)</td>
	<td class="cc" style="background-color:#ffffcc;">17 (50.0)</td>
</tr>
<tr>
	<td class="cl">Teicoplanin</td>
	<td class="cc">128 (R)</td>
	<td class="cc">10 (R)</td>
	<td class="cc">0 (0)</td>
	<td class="cc">0 (0)</td>
	<td class="cc">2 (100)</td>
</tr>
<tr>
	<td class="cl">Tetracyclin</td>
	<td class="cc">-</td>
	<td class="cc">6 (R)</td>
	<td class="cc">0 (0)</td>
	<td class="cc">0 (0)</td>
	<td class="cc">27 (100)</td>
</tr>
<tr>
	<td class="cl">Chloramphenicol</td>
	<td class="cc">16 (I)</td>
	<td class="cc">11 (R)</td>
	<td class="cc" style="background-color:#ffcccc;">20 (69)</td>
	<td class="cc" style="background-color:#ccffcc;">4 (13.8)</td>
	<td class="cc">5 (17.2)</td>
</tr>
<tr>
	<td class="cl"><font face="Symbol">b</font>-lactamase production</td>
	<td class="cc" colspan="2">Negative</td>
	<td class="cc" colspan="3">ND — 41 (82%),<br>Positive — 5 (10%),<br>Negative — 4 (8%)</td>
</tr>
<tr>
	<td class="cl">Identification</td>
	<td class="cc" colspan="2"><i>E.faecalis</i></td>
	<td class="cc" colspan="3"><i>E.faecalis</i> — 88%,<br><i>Enterococcus</i> spp. — 8%,<br><i>E.faecium</i> — 4%</td>
</tr>
</table>
</td></tr></table>
<a name="t4*"></a>
<p class="t8">* Broth microdilution screening test : streptomycin — 1000 mg/L, gentamicin — 500 mg/L</p>

<a name="t5"></a><br>
<p><b>Table 5.</b> The results of identification and AST of CDC-107<br>(<i>E.faecalis</i> — <i>vanB</i>-positive)</p>

<table border="0" cellpadding="0" cellspacing="10" width="100%"><tr><td bgcolor="#CC9988">
<table width="100%" cellpadding="5" cellspacing="1" border="0">
<tr>
	<th width="25%" rowspan="2">Antimicrobial</th>
	<th width="30%" colspan="2">CDC results</th>
	<th width="45%" colspan="3">Q-ty (%) of Labs reporting the result as</th>
</tr>
<tr>
	<th width="15%">MIC, mg/L</th>
	<th width="15%">Zone, mm</th>
	<th width="15%">S</th>
	<th width="15%">I</th>
	<th width="15%">R</th>
</tr>
<tr>
	<td class="cl">Ampicillin</td>
	<td class="cc">1 (S)</td>
	<td class="cc">20 (S)</td>
	<td class="cc">36 (80.0)</td>
	<td class="cc" style="background-color:#ccffcc;">3 (6.7)</td>
	<td class="cc">6 (13.3)</td>
</tr>
<tr>
	<td class="cl">Vancomycin</td>
	<td class="cc">16 (I)</td>
	<td class="cc">16 (I)</td>
	<td class="cc" style="background-color:#ccffcc;">16 (44.45)</td>
	<td class="cc">13 (36.1)</td>
	<td class="cc" style="background-color:#ccffcc;">7 (19.45)</td>
</tr>
<tr>
	<td class="cl">High Level Gentamicin Resistance</td>
	<td class="cc">R<a href="#t5*">*</a></td>
	<td class="cc">6 (R)</td>
	<td class="cc" style="background-color:#ffcccc;">8 (88.9)</td>
	<td class="cc" style="background-color:#ccffcc;">1 (11.1)</td>
	<td class="cc">0 (0)</td>
</tr>
<tr>
	<td class="cl">High Level Streptomycin Resistance</td>
	<td class="cc">R<a href="#t5*">*</a></td>
	<td class="cc">6 (R)</td>
	<td class="cc">0 (0)</td>
	<td class="cc">0 (0)</td>
	<td class="cc">4 (100)</td>
</tr>
<tr>
	<td class="cl">Penicillin</td>
	<td class="cc">4 (S)</td>
	<td class="cc">17 (S)</td>
	<td class="cc">6 (18.8)</td>
	<td class="cc" style="background-color:#ccffcc;">5 (15.6)</td>
	<td class="cc" style="background-color:#ffffcc;">21 (65.6)</td>
</tr>
<tr>
	<td class="cl">Teicoplanin</td>
	<td class="cc">0.25 (S)</td>
	<td class="cc">14 (S)</td>
	<td class="cc">1 (50.0)</td>
	<td class="cc">0 (0)</td>
	<td class="cc" style="background-color:#ffffcc;">1 (50.0)</td>
</tr>
<tr>
	<td class="cl">Tetracyclin</td>
	<td class="cc"><u>&lt;</u>1 (S)</td>
	<td class="cc">25 (S)</td>
	<td class="cc">21 (77.8)</td>
	<td class="cc" style="background-color:#ccffcc;">2 (7.4)</td>
	<td class="cc" style="background-color:#ffffcc;">4 (14.8)</td>
</tr>
<tr>
	<td class="cl">Chloramphenicol</td>
	<td class="cc">&gt;32 (R)</td>
	<td class="cc">8 (R)</td>
	<td class="cc">0 (0)</td>
	<td class="cc">0 (0)</td>
	<td class="cc">25 (100)</td>
</tr>
<tr>
	<td class="cl"><font face="Symbol">b</font>-lactamase production</td>
	<td class="cc" colspan="2">Negative</td>
	<td class="cc" colspan="3">ND — 46 (92%),<br>Positive — 1 (2%),<br>Negative — 3 (6%)</td>
</tr>
<tr>
	<td class="cl">Identification</td>
	<td class="cc" colspan="2"><i>E.faecalis</i></td>
	<td class="cc" colspan="3"><i>E.faecalis</i> — 88%,<br><i>Enterococcus</i> spp. — 10%,<br><i>E.faecium</i> — 2%</td>
</tr>

</table>
</td></tr></table>
<a name="t5*"></a>
<p class="t8">* Broth microdilution screening test : streptomycin — 1000 mg/L, gentamicin — 500 mg/L</p>

<p>The obtained results of testing of CDC control strains confirm that AST of clinical strains in routine practice in Russian microbiology laboratories produce a lot of errors.</p>

<p>Frequent problems with the AST and clinically significant resistance mechanisms detection in Gram-positive bacteria (MRSS, Vancomycin resistance and HLAGR in enterococci) were revealed.</p>

<p>The main reason of the majority of problems with AST is that the only official document regulating the AST procedure in Russia is the &quot;Methodical Rules&quot; by Ministry of Health of the USSR revised last time in 1983. This document advocates use of Russian AGV-medium for testing, composition of which differs considerably from Muller-Hinton agar and does not meet WHO requirements for cautions and thimidine contents, etc.</p>

<p>These guidelines include only disk-diffusion procedure of 23 &quot;old&quot; antimicrobials for non-fastidious bacteria only. No recommendations have been developed for dilution tests and screening of specific types of resistance (MRSS, Vancomycin resistance and HLAGR in enterococci, etc.)</p>

<a name="5"></a><br>
<h2>CONCLUSIONS</h2>

<ul>
<li>The above results elucidate the problems with the internal quality control in most Russian laboratories</li>
<li>Personnel education and procedures standardization are needed for the improvement of the present situation</li>
<li>There is a vast need for National guidelines for AST and detection of clinically significant resistance mechanisms (MRSS, HLAGR) in Gram-positive bacteria in Russia, harmonized with international practices (WHO, NCCLS, SFM, DIN, BSAC, etc.)</li>
</ul>

<a name="6"></a><br>
<h2>ACKNOWLEDGMENTS</h2>

<ul>
<li>We are indebted for Dr. Fred C.&nbsp;Tenover (Nosocomial Pathogens Laboratory Branch, CDC), Dr. Herve Richet, Jasmine Mohammed (WHO Collaborating Center) and INSPEAR project team for their kind permission to use the CDC control strains for IACMAC EQA program in Russia</li>
<li>We are grateful to our colleagues from Russian microbiology laboratories who participated in IACMAC EQA program</li>
</ul>

<hr size="1">

<br>
<!-- begin footer -->
<table border="0" cellpadding="5" cellspacing="0" width="100%">
<tr>
  <td style="text-align: left; vertical-align: bottom;" align="left" valign="bottom"><div class="t8">&copy; 2000-2006 IAC SSMA &middot; E-mail: <a href="mailto:website@antibiotic.ru" title="Send e-mail">website&#64;antibiotic&#46;ru</a></div></td>
  <td colspan="2" valign="top" align="right"><font size="1"><!-- SpyLOG v2 f:0211 --><script language="javascript">
u="u607.38.spylog.com";d=document;nv=navigator;na=nv.appName;p=1;
bv=Math.round(parseFloat(nv.appVersion)*100);
n=(na.substring(0,2)=="Mi")?0:1;rn=Math.random();z="p="+p+"&rn="+rn;y="";
y+="<a href='http://"+u+"/cnt?f=3&p="+p+"&rn="+rn+"' target=_blank>";
y+="<img src='http://"+u+"/cnt?"+z+
"&r="+escape(d.referrer)+"&pg="+escape(window.location.href)+"' border=0  width=88 height=31  alt='SpyLOG'>";
y+="</a>"; d.write(y);if(!n) { d.write("<"+"!--"); }//--></script><noscript>
<a href="../../../index-15.htm?f=3&p=1" target="_blank">
<img src="../../../digits.png?p=1" alt='SpyLOG' border='0' width="88" height="31">
</a></noscript><script language="javascript1.2"><!--
if(!n) { d.write("--"+">"); }//--></script><!-- SpyLOG  --></font></td>
</tr>
</table>
<!-- end of footer -->

  </td></tr>
</table>
</body>
</html>